Lumos Pharma Inc reports results for the quarter ended in September - Earnings Summary

Lumos Pharma

03/11/2021 21:38

* Lumos Pharma Inc  LUMO.OQ  reported a quarterly adjusted loss
of 90 cents​​ per share for the quarter ended in September. The
mean expectation of six analysts for the quarter was for a loss
of $1.07 per share.
* Reported revenue was zero​;  analysts expected zero. 
* Lumos Pharma Inc's reported EPS for the quarter was a loss
of 90 cents​.
* The mean earnings estimate of analysts had fallen by
about 0.8% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Lumos Pharma Inc shares had risen by 2.8% this quarter and
lost 72.6% so far this year.
* The company reported a quarterly loss of $7.49 million.
* Wall Street's median 12-month price target for Lumos Pharma
Inc is $26.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 3 at 09:38 p.m.
 ​All figures in US dollars unless otherwise stated